VGF and lung cancer: VGF, which is downregulated in older patients as well as in patients with high immune infiltrates, has also been reported to predict poor outcome and has been shown to promote chemoresistance in lung cancers with neuroendocrine features73 VGF may therefore negatively affect patient survival through mediating age and immune infiltration associated changes in LUAD.